content top

Macular Drusen, Atrophic AMD and Progression into Wet AMD

http://www.evrs.eu/medias/2010/congress/Age-Related-Macular-Degeneration-2.flv Ivan Fiser (Prague, Czech Republic) Advantages: 1. We find useful to carefully follow up eyes with atrophic AMD and macular drusen. Not only the drusen, but also the fading of drusen, and the conversion to geographic atrophy can be a prologue to CNV. The combination of OCT and FA, together with other usual examination methods, can distinguish between...

Read More

Surgical Treatment of Early AMD (drusen) with Vortex Vein Occlusion: 4 to 6 Years Follow Up of a Pilot Study

http://www.evrs.eu/medias/2010/congress/Age-Related-Macular-Degeneration-2.flv Richard Luscan (Paris, France) Advantages: There is extensive literature about the vascular component of the etiopathogenesis of AMD. Lutty brought histopathological evidence that in wet AMD, choriocapillaris (CC) disturbances precede RPE atrophy (2009). Bonnet was the first to perform Vortex Vein Occlusion (VVO) for wet forms of AMD in 17 human eyes (1983)....

Read More

Vortex Vein Occlusion as a Treatment for AMD: Surgical and Technical Procedure, Principle of Action, Indications and Results

http://www.evrs.eu/medias/2008/congress/Vortex-Vein-Occlusion-as-a-Treatment-for-AMD:-Surgical-and-Technical-Procedure,-Principle-of-Action,-Indications-and-Results.flv Richard Luscan Purpose: Report of a six year experience on this topic, including about one hundred procedures upon all various forms of AMD. Introduction: Vortex veins occlusion procedure was used to inflate the choriocapillaris tone, known to be deflated or with irregular...

Read More

Autologous Iris Pigment Epithelium Cell Transplantation for Treatment of Dry Macular Degeneration: 2 Year Follow-up

Narendra Armogan, MD, FRCS(C) (Mississauga, Canada), Fareed Ali, MD, FRCS(C) (Toronto, Canada), Alan Kosaric, MD (Oakville, Canada) PURPOSE: Can Autologous Iris Pigment Cell transplantation for Dry Macular Degeneration be used as a treatment to prevent the relentless progression of the disease as measured by functional and structural analysis; additionally, can improvement of visual acuity in patients by virtue of rescuing neuro-retinal...

Read More

Novel Macular Photorecovery Timer Detected Early Wet AMD Changes

David A. Newsome, MD (New Orleans, LA) PURPOSE: We tested the hypothesis that the macular photorecovery time becomes significantly prolonged with the start of wet AMD, and that the device used could detect the change. METHODS: Ten persons with advanced wet AMD in one eye and dry AMD in the other participated in this prospective, IRB approved study. The study eyes initially had dry AMD with corrected acuities 20/30 to 20/40, and at least one...

Read More

New Progress in the Surgical Treatment of AMD by Vortex Vein Occlusion

Richard Luscan, MD (Garches, France), P. Di Costanzo, (Saint Ouen, France), O. Polony, (Saint Ouen, France), R. Legac, (Saint Ouen, France), A. Chouquet, (Saint Ouen, France) PURPOSE: To demonstrate the efficacy of choriocapillaris repair surgery by vortex vein occlusion on various forms of AMD. METHODS: Several forms of AMD were treated surgically by vortex vein occlusion and were followed form March 2002 to March 2006. The basis of this...

Read More

Rheopheresis to Eradicate the Drusen – CNV Cascade

http://www.evrs.eu/medias/2005/congress/Rheopheresis-to-Eradicate-the-Drusen-CNV-Cascade.swf Frank Koch, MD, 1, Reiner Klingel, MD, 2, Cordula Fassbender, MD, 2 – 1 University Eye Clinic, Frankfurt/Main, Germany, 2 Apheresis Research Institute, Cologne, Germany Purpose: To update the current results of rheopheresis. Methods: Elimination of excact defined spectrum of high-molecular proteins from the blood circulation. The rheopheresis is...

Read More
content top